28 July 2022

Keensight Capital to acquire a majority stake in Axxam, a leading European partner research organization in life sciences

Keensight Capital has reached an agreement to invest alongside management in Axxam. Keensight Capital intends to support the management team in pursuing and accelerating the growth of the Company to realise its significant potential.
13 July 2022

Bio4Dreams and Gruppo Rold have signed a Memorandum of Understanding for the launch of BEEP Factory

The aim of BEEP Factory is to create a hub for the large number of research projects, either coming from academic research or from innovative startups R&D activity, where to find the competencies and infrastructures needed to transform a great idea in the bioengineering field into a valuable product.
27 June 2022

HealthTech Innovation Days, applications are now open for European innovative healthcare companies for the 4th edition

The event provides the platform and the opportunity of one-on-one meetings between companies, investors and industrial and pharmaceutical companies, as well as thematic panels led by international opinion leaders.
09 June 2022

Axxam announces license agreement with iPS Academia Japan to enhance further iPSC-based discovery services

The license agreement allows Axxam to provide state of the art discovery services using human iPSCs and iPSC-derived cells to its clients.
31 May 2022

Evotec adds cell theraphy manufacturing facility with acquisition of Rigenerand

Evotec's Evocells platform integrates innovative off-the-shelf ipsc cell therapy discovery with development and manufacturing
12 May 2022

Assobiotec and Campus Biotech Digital together signed the agreement for improving and developing skills for biological medical product

An opportunity for reskilling and upskilling employees expertise and young graduateds competences


Where to find us

20149 Milan
Via Giovanni da Procida, 11
Show map 
Tel. +39 02.34565.1
Fax. +39 02.34565.310
Segreteria Assobiotec
Tel. 02 34565.256/341